{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T23:55:25Z","timestamp":1772495725457,"version":"3.50.1"},"reference-count":80,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Background\/Objectives: Population aging is a worldwide phenomenon and is often associated with multimorbidity and polypharmacy. Complex medication regimens are common among older adults and contribute to the occurrence of harmful health outcomes. Age is one of the main risk factors for cancer. This study aimed to determine and characterize the therapeutic complexity in older patients with cancer, and analyze the factors associated with high complexity and the impact of the oncological context. Methods: A cross-sectional study with patients aged \u226565 years with cancer was conducted in three hospitals in northern Portugal. Data collection was obtained using self-reports. The medication regimen complexity was assessed using the Medication Regimen Complexity Index (MRCI). Descriptive and association statistical analysis were performed. Logistic, linear, simple and multiple regression analysis were conducted, with and without automatic variable selection. Results: A total of 552 patients were included (median age, 71; IQR, 68\u201376). The mean MRCI before the oncological context was 18.67 (SD 12.60) and 27.39 (SD 16.67) after the oncological context, presenting a statistically significant difference in the values obtained (p &lt; 0.001). An elevated complexity was significantly associated with polypharmacy, chronic diseases and with the administration of high-risk medications (p &lt; 0.05). High MRCI values showed a relationship with the occurrence of potential drug interactions (p &lt; 0.001). There was no relationship with the existence of cardiac risk comorbidity. Conclusions: This study demonstrated the existence of high therapeutic complexity in older patients with cancer, suggesting the need for intervention to prevent medication-related problems in this vulnerable population.<\/jats:p>","DOI":"10.3390\/ph17111541","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T05:36:45Z","timestamp":1731908205000},"page":"1541","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Complexity of the Therapeutic Regimen in Older Adults with Cancer: Associated Factors"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3933-5740","authenticated-orcid":false,"given":"Rita F.","family":"Oliveira","sequence":"first","affiliation":[{"name":"REQUIMTE\/LAQV, ESS, Polytechnic of Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida 400, 4200-072 Porto, Portugal"},{"name":"Center for Health Technology and Services Research at the Associate Laboratory RISE\u2014Health Research Network (CINTESIS@RISE), Department of Education and Psychology, University of Aveiro (UA), 3810-193 Aveiro, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4420-6476","authenticated-orcid":false,"given":"Ana I.","family":"Oliveira","sequence":"additional","affiliation":[{"name":"REQUIMTE\/LAQV, ESS, Polytechnic of Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida 400, 4200-072 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1157-8196","authenticated-orcid":false,"given":"Agostinho","family":"Cruz","sequence":"additional","affiliation":[{"name":"REQUIMTE\/LAQV, ESS, Polytechnic of Porto, Rua Dr. Ant\u00f3nio Bernardino de Almeida 400, 4200-072 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4740-7951","authenticated-orcid":false,"given":"Oscar","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Center for Health Technology and Services Research at the Associate Laboratory RISE\u2014Health Research Network (CINTESIS@RISE), Department of Education and Psychology, University of Aveiro (UA), 3810-193 Aveiro, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1051-8084","authenticated-orcid":false,"given":"Vera","family":"Afreixo","sequence":"additional","affiliation":[{"name":"Center for Research and Development in Mathematics and Applications (CIDMA), Department of Mathematics, University of Aveiro (UA), 3810-193 Aveiro, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5993-5132","authenticated-orcid":false,"given":"Francisco","family":"Pimentel","sequence":"additional","affiliation":[{"name":"BlueClinical, 4460-439 Matosinhos, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,16]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2024, January 09). Global Health and Aging. Bethesda, MD: National Institute on Aging, National Institutes of Health. World Health Organization, Available online: https:\/\/www.nia.nih.gov\/sites\/default\/files\/2017-06\/global_health_aging.pdf."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.arr.2011.03.003","article-title":"Aging with multimorbidity: A systematic review of the literature","volume":"10","author":"Marengoni","year":"2011","journal-title":"Ageing Res. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2042098620933741","DOI":"10.1177\/2042098620933741","article-title":"An overview of prevalence, determinants and health outcomes of polypharmacy","volume":"11","author":"Khezrian","year":"2020","journal-title":"Ther. Adv. Drug Saf."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s11096-014-9963-4","article-title":"Medication regimen complexity in institutionalized elderly people in an aging society","volume":"36","author":"Advinha","year":"2014","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(07)61091-5","article-title":"Appropriate prescribing in elderly people: How well can it be measured and optimised?","volume":"370","author":"Spinewine","year":"2007","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Dixe, M.d.A., Pinho, J., Pereira, F., Verloo, H., Meyer-Massetti, C., and Pereira, S.G. (2023). Patterns of Medication Management and Associated Medical and Clinical Features Among Home-Dwelling Older Adults: A Cross-Sectional Study in Central Portugal. Int. J. Environ. Res. Public Health, 20.","DOI":"10.3390\/ijerph20031701"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.amjopharm.2007.12.002","article-title":"Polypharmacy in elderly patients","volume":"5","author":"Hajjar","year":"2007","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11096-016-0409-z","article-title":"Assessment of the elderly\u2019s functional ability to manage their medication: A systematic literature review","volume":"39","author":"Advinha","year":"2017","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00228-015-1883-2","article-title":"Factors associated with medication regimen complexity in older people: A cross-sectional population-based study","volume":"71","author":"Wimmer","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Berben, L., Floris, G., Wildiers, H., and Hatse, S. (2021). Cancer and Aging: Two Tightly Interconnected Biological Processes. Cancers, 13.","DOI":"10.3390\/cancers13061400"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA A Cancer J. Clin."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jgo.2020.03.001","article-title":"Relationship between polypharmacy and inpatient hospitalization among older adults with cancer treated with intravenous chemotherapy","volume":"11","author":"Nightingale","year":"2020","journal-title":"J. Geriatr. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40266-023-01076-8","article-title":"Prevalence of and Risk Factors for Drug-Related Readmissions in Older Adults: A Systematic Review and Meta-Analysis","volume":"41","author":"Prasad","year":"2024","journal-title":"Drugs Aging"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Alves-Conceicao, V., Silva, D.T.D., Santana, V.L., Santos, E.G.D., Santos, L.M.C., and Lyra, D.P. (2017). Evaluation of pharmacotherapy complexity in residents of long-term care facilities: A cross-sectional descriptive study. BMC Pharmacol. Toxicol., 18.","DOI":"10.1186\/s40360-017-0164-3"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00228-016-2075-4","article-title":"Polypharmacy and medication regimen complexity as factors associated with staff informant rated quality of life in residents of aged care facilities: A cross-sectional study","volume":"72","author":"Lalic","year":"2016","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_19","first-page":"659","article-title":"Medication regimen complexity in adults and the elderly in a primary healthcare setting: Determination of high and low complexities","volume":"13","author":"Ferreira","year":"2015","journal-title":"Pharm. Pract."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e000685","DOI":"10.1136\/bmjdrc-2019-000685","article-title":"Medication regimen complexity and its impact on medication adherence and glycemic control among patients with type 2 diabetes mellitus in an Ethiopian general hospital","volume":"7","author":"Ayele","year":"2019","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_21","first-page":"814","article-title":"The implications of therapeutic complexity on adherence to cardiovascular medications","volume":"171","author":"Choudhry","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"ref_22","first-page":"301","article-title":"Are Clinical Outcomes Associated with Medication Regimen Complexity? A Systematic Review and Meta-Analysis","volume":"54","author":"Rocha","year":"2019","journal-title":"Ann. Pharmacother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1177\/1060028018773691","article-title":"Medication Regimen Complexity Measured by MRCI: A Systematic Review to Identify Health Outcomes","volume":"52","author":"Rocha","year":"2018","journal-title":"Ann. Pharmacother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/jgs.14682","article-title":"Clinical Outcomes Associated with Medication Regimen Complexity in Older People: A Systematic Review","volume":"65","author":"Wimmer","year":"2017","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00228-017-2315-2","article-title":"Association between medication regimen complexity and pharmacotherapy adherence: A systematic review","volume":"73","author":"Pantuzza","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpsychores.2013.11.003","article-title":"Medication beliefs, treatment complexity, and non-adherence to different drug classes in patients with type 2 diabetes","volume":"76","author":"Keers","year":"2014","journal-title":"J. Psychosom. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4140\/TCP.n.2017.281","article-title":"Medication Regimen Complexity in Long-Term Care Facilities and Adverse Drug Events-Related Hospitalizations","volume":"32","author":"Tam","year":"2017","journal-title":"Consult. Pharm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s11096-010-9431-8","article-title":"Association between drug prescribing and quality of life in primary care","volume":"32","author":"Frohlich","year":"2010","journal-title":"Pharm. World Sci. PWS"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/PTS.0000000000000067","article-title":"Predicting potential postdischarge adverse drug events and 30-day unplanned hospital readmissions from medication regimen complexity","volume":"10","author":"Schoonover","year":"2014","journal-title":"J. Patient Saf."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s40266-014-0185-1","article-title":"Polypharmacy and medication regimen complexity as factors associated with hospital discharge destination among older people: A prospective cohort study","volume":"31","author":"Wimmer","year":"2014","journal-title":"Drugs Aging"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1345\/aph.1D479","article-title":"Development and validation of the medication regimen complexity index","volume":"38","author":"George","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1590\/S0066-782X2007001600001","article-title":"Translation and validation into Portuguese language of the medication regimen complexity index","volume":"89","author":"Melchiors","year":"2007","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2753.2011.01636.x","article-title":"Development and psychometric evaluation of the German version of the Medication Regimen Complexity Index (MRCI-D)","volume":"18","author":"Stange","year":"2012","journal-title":"J. Eval. Clin. Pract."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1177\/1060028016656385","article-title":"Cross-cultural Adaptation and Validation of the Medication Regimen Complexity Index Adapted to Spanish","volume":"50","author":"Ramila","year":"2016","journal-title":"Ann. Pharmacother."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Lee, S., Jang, J., Yang, S., Hahn, J., Min, K.L., Jung, E.H., Oh, K.S., Cho, R., and Chang, M.J. (2019). Development and validation of the Korean version of the medication regimen complexity index. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0216805"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/jep.12526","article-title":"Validation of the Turkish version of medication regimen complexity index among elderly patients","volume":"22","author":"Okuyan","year":"2016","journal-title":"J. Eval. Clin. Pract."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Falch, C., and Alves, G. (2021). Pharmacists\u2019 Role in Older Adults\u2019 Medication Regimen Complexity: A Systematic Review. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18168824"},{"key":"ref_38","first-page":"484","article-title":"Medication Regimen Complexity Index in the Elderly in an Outpatient Setting: A Literature Review","volume":"33","author":"Brysch","year":"2018","journal-title":"Consult. Pharm. J. Am. Soc. Consult. Pharm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1517\/14740338.2013.823944","article-title":"Complexity perplexity: A systematic review to describe the measurement of medication regimen complexity","volume":"12","author":"Paquin","year":"2013","journal-title":"Expert. Opin. Drug Saf."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/ggi.13261","article-title":"Validation and standardization of the Brazilian version of the Medication Regimen Complexity Index for older adults in primary care","volume":"18","author":"Pantuzza","year":"2018","journal-title":"Geriatr. Gerontol. Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.amjopharm.2012.06.002","article-title":"Looking beyond polypharmacy: Quantification of medication regimen complexity in the elderly","volume":"10","author":"Mansur","year":"2012","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/phar.1452","article-title":"Validation of a patient-level medication regimen complexity index as a possible tool to identify patients for medication therapy management intervention","volume":"34","author":"Hirsch","year":"2014","journal-title":"Pharmacotherapy"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.clinthera.2013.02.019","article-title":"Patient-level medication regimen complexity across populations with chronic disease","volume":"35","author":"Libby","year":"2013","journal-title":"Clin. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"104117","DOI":"10.1016\/j.critrevonc.2023.104117","article-title":"Enhancing collaboration between geriatricians, oncologists, and pharmacists to optimize medication therapy in older adults with cancer: A position paper from SOFOG-SFPO","volume":"190","author":"Herledan","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/1060028015621071","article-title":"Medication Regimen Complexity and Polypharmacy as Factors Associated with All-Cause Mortality in Older People: A Population-Based Cohort Study","volume":"50","author":"Wimmer","year":"2016","journal-title":"Ann. Pharmacother."},{"key":"ref_46","first-page":"470","article-title":"Medication Regimen Complexity and Risk of Bleeding in People Who Initiate Oral Anticoagulants for Atrial Fibrillation: A Population-Based Study","volume":"78","author":"Chen","year":"2023","journal-title":"J. Gerontol. Ser. A-Biol. Sci. Med. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Krska, J., Corlett, S.A., and Katusiime, B. (2019). Complexity of Medicine Regimens and Patient Perception of Medicine Burden. Pharmacy, 7.","DOI":"10.3390\/pharmacy7010018"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2147\/CIA.S130832","article-title":"Medication regimen complexity in ambulatory older adults with heart failure","volume":"12","author":"Cobretti","year":"2017","journal-title":"Clin. Interv. Aging"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Tesfaye, W.H., Peterson, G.M., Castelino, R.L., McKercher, C., Jose, M., Zaidi, S.T.R., and Wimmer, B.C. (2019). Medication-Related Factors and Hospital Readmission in Older Adults with Chronic Kidney Disease. J. Clin. Med., 8.","DOI":"10.3390\/jcm8030395"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/gerona\/glv219","article-title":"Medication Regimen Complexity and Number of Medications as Factors Associated with Unplanned Hospitalizations in Older People: A Population-Based Cohort Study","volume":"71","author":"Wimmer","year":"2016","journal-title":"J. Gerontol. Ser. A Biol. Sci. Med. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/0733464817714565","article-title":"Medication Regimen Complexity and Low Adherence in Older Community-Dwelling Adults with Substantiated Self-Neglect","volume":"38","author":"Abada","year":"2019","journal-title":"J. Appl. Gerontol. Off. J. South. Gerontol. Soc."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s11096-017-0490-y","article-title":"Medication regimen complexity and prevalence of potentially inappropriate medicines in older patients after hospitalisation","volume":"39","author":"Chang","year":"2017","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.clinthera.2014.10.004","article-title":"Patient-level medication regimen complexity in older adults with depression","volume":"36","author":"Linnebur","year":"2014","journal-title":"Clin. Ther."},{"key":"ref_54","first-page":"342","article-title":"Complexity of the medication regimen for polypathological patients","volume":"218","year":"2018","journal-title":"Rev. Clin. Esp."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1007\/s11096-018-0681-1","article-title":"The association between polypharmacy and medication regimen complexity and antibiotic use in bronchiectasis","volume":"40","author":"Spargo","year":"2018","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/jac5.1146","article-title":"Medication regimen complexity is associated with pharmacist interventions and drug-drug interactions: A use of the novel MRC-ICU scoring tool","volume":"3","author":"Newsome","year":"2020","journal-title":"J. Am. Coll. Clin. Pharm."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1331\/JAPhA.2013.13003","article-title":"Medication regimen complexity in patients with uncontrolled hypertension and\/or diabetes","volume":"53","author":"Rettig","year":"2013","journal-title":"J. Am. Pharm. Assoc."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Ab Rahman, N., Lim, M.T., Thevendran, S., Ahmad Hamdi, N., and Sivasampu, S. (2022). Medication Regimen Complexity and Medication Burden Among Patients with Type 2 Diabetes Mellitus: A Retrospective Analysis. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.808190"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMsa1103053","article-title":"Emergency hospitalizations for adverse drug events in older Americans","volume":"365","author":"Budnitz","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Gnjidic, D., Hilmer, S.N., Hartikainen, S., Tolppanen, A.M., Taipale, H., Koponen, M., and Bell, J.S. (2014). Impact of high risk drug use on hospitalization and mortality in older people with and without Alzheimer\u2019s disease: A national population cohort study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0083224"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/1060028018793419","article-title":"Medication Regimen Complexity and Hospital Readmission in Older Adults with Chronic Kidney Disease","volume":"53","author":"Tesfaye","year":"2019","journal-title":"Ann. Pharmacother."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s41999-019-00275-0","article-title":"Factors associated with high medication regimen complexity in primary care older adults in Brazil","volume":"11","author":"Pantuzza","year":"2020","journal-title":"Eur. Geriatr. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1177\/1060028016657552","article-title":"Evaluating Patient-Level Medication Regimen Complexity over Time in Heart Transplant Recipients","volume":"50","author":"Bryant","year":"2016","journal-title":"Ann. Pharmacother."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1177\/1060028014539642","article-title":"Patient-Level Medication Regimen Complexity in Patients with HIV","volume":"48","author":"Metz","year":"2014","journal-title":"Ann. Pharmacother."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.sapharm.2016.10.002","article-title":"Discharge medication complexity and 30-day heart failure readmissions","volume":"13","author":"Colavecchia","year":"2017","journal-title":"Res. Soc. Adm. Pharm."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijmedinf.2015.10.004","article-title":"Clustering of elderly patient subgroups to identify medication-related readmission risks","volume":"85","author":"Olson","year":"2016","journal-title":"Int. J. Med. Inform."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1067.e1","DOI":"10.1016\/j.jamda.2016.08.019","article-title":"Polypharmacy and Medication Regimen Complexity as Risk Factors for Hospitalization Among Residents of Long-Term Care Facilities: A Prospective Cohort Study","volume":"17","author":"Lalic","year":"2016","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1060028013510898","article-title":"Medication regimen complexity and hospital readmission for an adverse drug event","volume":"48","author":"Willson","year":"2014","journal-title":"Ann. Pharmacother."},{"key":"ref_69","first-page":"396","article-title":"Reducing cardiovascular medication complexity in a German university hospital: Effects of a structured pharmaceutical management intervention on adherence","volume":"19","author":"Stange","year":"2013","journal-title":"J. Manag. Care Pharm. JMCP"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/amiajnl-2012-001272","article-title":"Automating the medication regimen complexity index","volume":"20","author":"McDonald","year":"2013","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1331\/JAPhA.2014.14542","article-title":"Medication regimen complexity indices: A tool to focus MTM efforts?","volume":"54","author":"Clay","year":"2014","journal-title":"J. Am. Pharm. Assoc."},{"key":"ref_72","first-page":"1184","article-title":"Adaptation and validation into Portuguese language of the six-item cognitive impairment test (6CIT)","volume":"22","author":"Paiva","year":"2018","journal-title":"Aging Ment. Health"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1634\/theoncologist.2019-0085","article-title":"Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy","volume":"25","author":"Hong","year":"2020","journal-title":"Oncologist"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1111\/jgs.12942","article-title":"Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: Effect on chemotherapy-related toxicity and hospitalization during treatment","volume":"62","author":"Maggiore","year":"2014","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jgo.2012.02.005","article-title":"Patient Characteristics Associated with Polypharmacy and Inappropriate Prescribing of Medications Among Older Adults with Cancer","volume":"3","author":"Prithviraj","year":"2012","journal-title":"J. Geriatr. Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1634\/theoncologist.2009-0290","article-title":"Polypharmacy in older adults with cancer","volume":"15","author":"Maggiore","year":"2010","journal-title":"Oncologist"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00228-017-2266-7","article-title":"Polypharmacy and mortality: New insights from a large cohort of older adults by detection of effect modification by multi-morbidity and comprehensive correction of confounding by indication","volume":"73","author":"Saum","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_78","unstructured":"Micromedex\u00ae (2016, January 09). Drug Interaction Checking (Electronic Version) Health. Available online: https:\/\/www.micromedexsolutions.com\/home\/dispatch\/."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1200\/JOP.2016.016212","article-title":"Drug Interaction Database Sensitivity with Oral Antineoplastics: An Exploratory Analysis","volume":"13","author":"Bossaer","year":"2017","journal-title":"J. Oncol. Pract."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/intqhc\/mzq004","article-title":"OncoRx-IQ: A tool for quality assessment of online anticancer drug interactions","volume":"22","author":"Yap","year":"2010","journal-title":"Int. J. Qual. Health Care"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/11\/1541\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:33:39Z","timestamp":1760114019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/11\/1541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,16]]},"references-count":80,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["ph17111541"],"URL":"https:\/\/doi.org\/10.3390\/ph17111541","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,16]]}}}